what to expect taking glp 1 How Do You Know When Semaglutide GLP-1 Is Working? GLP-1 Clinical Guidance vs Patient

Novos GLP-1 revenue generated around $35 billion in 2025, about 75% of the companys annual revenue

Because of these immediate reactions, food allergies are easier to identify

The Current Gap in GLP-1 Nutrition Guidance Traditional medical weight loss approaches often leave patients navigating nutrition alone after receiving their prescription

(MCL Case 644) Status of Ozempic label: In January 2025, the FDA updated the Ozempic label to include that it is not recommended in patients with severe gastroparesis. However, the amended label for whatever reason does not state that the medication itself could lead to gastroparesis

The study reviewed patient data to evaluate long term neurological outcomes among individuals using GLP-1 medications for diabetes and weight loss

The approval of the once-daily injection (18 mg/3 mL), as an adjunct to diet and exercise, is intended to help with drug shortages and improve patient access